GMP Versus Non GMP Peptides and Quality A peptide can present a high assay result and still be a poor fit for a controlled research workflow. That is the practical issue behind GMP versus non GMP peptides: the comparison is not limited to a single purity number. It...
MOTS-c Research Requires a Precision Framework MOTS-c is frequently discussed as a mitochondrial-derived peptide with relevance to metabolic stress signaling, but that description is only the starting point for serious laboratory work. For researchers, the central...
Peptide Supplier Evaluation Checklist for Labs A peptide that arrives with an impressive purity claim but no batch-specific analytical record creates a preventable problem: your laboratory must spend time establishing facts that the supplier should already document. A...
Glow Is Not a Metric in Peptide Research A photograph can suggest a visible glow, but it cannot establish what changed, why it changed, or whether the observation can be reproduced. For laboratory researchers evaluating peptide-related aesthetic or longevity pathways,...
Are Peptides FDA Approved? The Research Reality A peptide’s molecular identity does not determine its FDA status. The intended use, finished dosage form, labeling, manufacturing controls, clinical evidence, and marketing claims determine the regulatory pathway. That...
NAD+: Research Priorities for Quality and Control NAD+ is often discussed as a longevity-related molecule, but the laboratory question is more exacting: what material is being measured, under what conditions, and how confidently can the result be reproduced? For...
